[BVED regimen bridging auto-HSCT in relapsed/refractory aggressive lymphoma accompany hemophagocytic lymphocytic histiocytosis: two cases report].
Zhonghua Xue Ye Xue Za Zhi
; 43(8): 696-697, 2022 08 14.
Article
in Zh
| MEDLINE
| ID: mdl-36709159
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Histiocytosis
/
Hematopoietic Stem Cell Transplantation
/
Lymphoma
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2022
Type:
Article
Affiliation country:
China